Pharma-Deko Past Earnings Performance

Past criteria checks 0/6

Pharma-Deko's earnings have been declining at an average annual rate of -102.9%, while the Beverage industry saw earnings growing at 9% annually. Revenues have been declining at an average rate of 6.7% per year.

Key information

-102.9%

Earnings growth rate

-102.9%

EPS growth rate

Beverage Industry Growth47.0%
Revenue growth rate-6.7%
Return on equity-12.1%
Net Margin-30.2%
Last Earnings Update31 Dec 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Pharma-Deko makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGSE:PHARMDEKO Revenue, expenses and earnings (NGN Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 22470-1421950
30 Sep 22461-1152110
30 Jun 22445-1112250
31 Mar 22505-1072390
31 Dec 21504-702180
30 Sep 21530-2142780
30 Jun 21632-1673170
31 Mar 21520-2453250
31 Dec 20461-3253820
30 Sep 20488-1763350
30 Jun 20351-2403930
31 Mar 20468-2564920
31 Dec 19485-2795310
30 Sep 19544-4136260
30 Jun 19613-4736260
31 Mar 19717-3996030
31 Dec 181,024-2656570
30 Sep 181,300-976830
30 Jun 181,580617100
31 Mar 181,657397600
31 Dec 171,593137200
30 Sep 171,456-1157930
30 Jun 171,414-1267760
31 Mar 171,263-1647450
31 Dec 161,095-2197340
30 Sep 161,095-311,2420
30 Jun 161,0253801,2470
31 Mar 161,3495821,2680
31 Dec 151,4826591,2680
30 Sep 151,5285407390
30 Jun 151,5961357160
31 Mar 151,5771047240
31 Dec 141,5661017050
30 Sep 141,4911576090
30 Jun 141,357767910
31 Mar 141,106-676020
31 Dec 131,060-1214720
30 Sep 131,042-1257700
30 Jun 131,0856434490

Quality Earnings: PHARMDEKO is currently unprofitable.

Growing Profit Margin: PHARMDEKO is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if PHARMDEKO's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare PHARMDEKO's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PHARMDEKO is unprofitable, making it difficult to compare its past year earnings growth to the Beverage industry (33.5%).


Return on Equity

High ROE: PHARMDEKO has a negative Return on Equity (-12.14%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.